Literature DB >> 24614907

Optimizing patient care and research: the Amsterdam Dementia Cohort.

Wiesje M van der Flier1, Yolande A L Pijnenburg2, Niels Prins2, Afina W Lemstra2, Femke H Bouwman2, Charlotte E Teunissen3, Bart N M van Berckel4, Cornelis J Stam5, Frederik Barkhof4, Pieter Jelle Visser2, Evan van Egmond2, Philip Scheltens2.   

Abstract

Since its opening in 2000, patient care and research go hand in hand at the Alzheimer center of the VU University Medical Center, both organized in such a way that they mutually strengthen each other. Our mission is to give patients a voice by lifting the stigma on dementia, to find new diagnostic and treatment strategies, and, ultimately, to cure diseases that cause dementia. Our healthcare pathway is uniquely designed to accommodate all necessary investigations for the diagnostic work-up of dementia in one day (one-stop shop). A second unique feature is that research has been fully integrated in the healthcare pathway. The resulting Amsterdam Dementia Cohort now includes over 4000 patients, and for the majority of these, we have MRI, EEG, blood (serum, plasma), DNA, and CSF available. The Amsterdam Dementia Cohort forms the basis of much of our research, which focuses on four major research lines: 1) variability in manifestation, 2) early diagnosis, 3) vascular factors, and 4) interventions. By answering research questions closely related to clinical practice, the results of our research can be looped back to improve clinical work-up for our patients.

Entities:  

Keywords:  Alzheimer's disease; dementia; diagnosis; investigations; mild cognitive impairment; work-up

Mesh:

Year:  2014        PMID: 24614907     DOI: 10.3233/JAD-132306

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  154 in total

1.  Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.

Authors:  Jon B Toledo; Henrik Zetterberg; Argonde C van Harten; Lidia Glodzik; Pablo Martinez-Lage; Luisella Bocchio-Chiavetto; Lorena Rami; Oskar Hansson; Reisa Sperling; Sebastiaan Engelborghs; Ricardo S Osorio; Hugo Vanderstichele; Manu Vandijck; Harald Hampel; Stefan Teipl; Abhay Moghekar; Marilyn Albert; William T Hu; Jose A Monge Argilés; Ana Gorostidi; Charlotte E Teunissen; Peter P De Deyn; Bradley T Hyman; Jose L Molinuevo; Giovanni B Frisoni; Gurutz Linazasoro; Mony J de Leon; Wiesje M van der Flier; Philip Scheltens; Kaj Blennow; Leslie M Shaw; John Q Trojanowski
Journal:  Brain       Date:  2015-07-27       Impact factor: 13.501

2.  A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease.

Authors:  Anna C van Loenhoud; Alle Meije Wink; Colin Groot; Sander C J Verfaillie; Jos Twisk; Frederik Barkhof; Bart van Berckel; Philip Scheltens; Wiesje M van der Flier; Rik Ossenkoppele
Journal:  Hum Brain Mapp       Date:  2017-06-20       Impact factor: 5.038

3.  PLD3 variants in population studies.

Authors:  Sven J van der Lee; Henne Holstege; Tsz Hang Wong; Johanna Jakobsdottir; Joshua C Bis; Vincent Chouraki; Jeroen G J van Rooij; Megan L Grove; Albert V Smith; Najaf Amin; Seung-Hoan Choi; Alexa S Beiser; Melissa E Garcia; Wilfred F J van IJcken; Yolande A L Pijnenburg; Eva Louwersheimer; Rutger W W Brouwer; Mirjam C G N van den Hout; Edwin Oole; Gudny Eirkisdottir; Daniel Levy; Jerome I Rotter; Valur Emilsson; Christopher J O'Donnell; Thor Aspelund; Andre G Uitterlinden; Lenore J Launer; Albert Hofman; Eric Boerwinkle; Bruce M Psaty; Anita L DeStefano; Philip Scheltens; Sudha Seshadri; John C van Swieten; Vilmundur Gudnason; Wiesje M van der Flier; M Arfan Ikram; Cornelia M van Duijn
Journal:  Nature       Date:  2015-04-02       Impact factor: 49.962

4.  Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project.

Authors:  Arno de Wilde; Wiesje M van der Flier; Wiesje Pelkmans; Femke Bouwman; Jurre Verwer; Colin Groot; Marieke M van Buchem; Marissa Zwan; Rik Ossenkoppele; Maqsood Yaqub; Marleen Kunneman; Ellen M A Smets; Frederik Barkhof; Adriaan A Lammertsma; Andrew Stephens; Erik van Lier; Geert Jan Biessels; Bart N van Berckel; Philip Scheltens
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

5.  Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease.

Authors:  Rik Ossenkoppele; Niklas Mattsson; Charlotte E Teunissen; Frederik Barkhof; Yolande Pijnenburg; Philip Scheltens; Wiesje M van der Flier; Gil D Rabinovici
Journal:  Neurobiol Aging       Date:  2015-04-25       Impact factor: 4.673

6.  Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.

Authors:  Lisa Vermunt; Sietske A M Sikkes; Ardo van den Hout; Ron Handels; Isabelle Bos; Wiesje M van der Flier; Silke Kern; Pierre-Jean Ousset; Paul Maruff; Ingmar Skoog; Frans R J Verhey; Yvonne Freund-Levi; Magda Tsolaki; Åsa K Wallin; Marcel Olde Rikkert; Hilkka Soininen; Luisa Spiru; Henrik Zetterberg; Kaj Blennow; Philip Scheltens; Graciela Muniz-Terrera; Pieter Jelle Visser
Journal:  Alzheimers Dement       Date:  2019-06-01       Impact factor: 21.566

7.  Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts.

Authors:  Nienke M E Scheltens; Betty M Tijms; Teddy Koene; Frederik Barkhof; Charlotte E Teunissen; Steffen Wolfsgruber; Michael Wagner; Johannes Kornhuber; Oliver Peters; Brendan I Cohn-Sheehy; Gil D Rabinovici; Bruce L Miller; Joel H Kramer; Philip Scheltens; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2017-04-17       Impact factor: 21.566

8.  Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.

Authors:  Rosalinde E R Slot; Sietske A M Sikkes; Johannes Berkhof; Henry Brodaty; Rachel Buckley; Enrica Cavedo; Efthimios Dardiotis; Francoise Guillo-Benarous; Harald Hampel; Nicole A Kochan; Simone Lista; Tobias Luck; Paul Maruff; José Luis Molinuevo; Johannes Kornhuber; Barry Reisberg; Steffi G Riedel-Heller; Shannon L Risacher; Susanne Roehr; Perminder S Sachdev; Nikolaos Scarmeas; Philip Scheltens; Melanie B Shulman; Andrew J Saykin; Sander C J Verfaillie; Pieter Jelle Visser; Stephanie J B Vos; Michael Wagner; Steffen Wolfsgruber; Frank Jessen; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2018-12-13       Impact factor: 21.566

9.  The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

Authors:  Rik Ossenkoppele; Yolande A L Pijnenburg; David C Perry; Brendan I Cohn-Sheehy; Nienke M E Scheltens; Jacob W Vogel; Joel H Kramer; Annelies E van der Vlies; Renaud La Joie; Howard J Rosen; Wiesje M van der Flier; Lea T Grinberg; Annemieke J Rozemuller; Eric J Huang; Bart N M van Berckel; Bruce L Miller; Frederik Barkhof; William J Jagust; Philip Scheltens; William W Seeley; Gil D Rabinovici
Journal:  Brain       Date:  2015-07-02       Impact factor: 13.501

10.  Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.

Authors:  Mara Ten Kate; Ellen Dicks; Pieter Jelle Visser; Wiesje M van der Flier; Charlotte E Teunissen; Frederik Barkhof; Philip Scheltens; Betty M Tijms
Journal:  Brain       Date:  2018-12-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.